188 studies found for:    Open Studies | "Heparin"
Show Display Options
Rank Status Study
21 Not yet recruiting PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
Condition: Healthy
Intervention: Drug: Heparin
22 Unknown  ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.
Conditions: The Primary Study Objective is to Assess the Efficacy and;   Safety of Extended 4-week Heparin Prophylaxis Compared to;   Prophylaxis Given for 8±2 Days After Planned Laparoscopic;   Surgery for Colorectal Cancer.;   The Clinical Benefit Will be Evaluated as the Difference in;   the Incidence of VTE or VTE-related Death Occurring Within 30 Days;   From Surgery in the Two Study Groups.
Intervention: Drug: Heparin, Low-Molecular-Weight
23 Recruiting Propaten Randomized Investigation on Cost-benefit and Efficacy
Condition: End-stage Renal Disease
Interventions: Device: Heparin-bonded vascular access graft;   Device: Conventional ePTFE hemodialysis graft
24 Unknown  Comparison of Slow Efficiency Daily Dialysis (SLEDD) With Unfractionated Heparin Versus Citrasate in Critically Ill Patients.
Conditions: Acute Kidney Injury;   Hemodialysis
Interventions: Drug: Unfractionated heparin;   Drug: Citrasate
25 Unknown  Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Condition: Deep Venous Thrombosis
Intervention: Drug: Low-Molecular-Weight Heparin
26 Recruiting Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
Conditions: Acute Chest Syndrome;   Sickle Cell Disease
Intervention: Drug: Unfractionated heparin
27 Recruiting Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances
Condition: Septic Shock
Interventions: Drug: Anticoagulation to prevent clotting of the extracorporeal circuit. (regional citrate anticoagulation);   Drug: Anticoagulation to prevent clotting of the extracorporeal circuit (Unfractionated heparin)
28 Recruiting Clinical Outcomes About Heparin Surface Modified Aspheric Lens
Condition: Inflammatory Reaction
Interventions: Device: traditional lens;   Device: heparin surface modified aspheric lens
29 Unknown  Effect of a Pre Heparin Coated Dialysis Filter on Coagulation During Hemodialysis
Condition: Renal Failure
Intervention: Device: a pre-heparin-coated hemodialysis filter; Hepran
30 Unknown  CATCH - Catheter Infections in Children
Condition: Catheter-Related Infections
Interventions: Device: Standard polyurethane Central Venous Catheter;   Device: Antibiotic impregnated polyurethane CVC (minocycline and rifampicin);   Device: Heparin bonded polyurethane CVC
31 Unknown  Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure
Condition: Thrombosis
Intervention: Drug: Low molecular weight heparin
32 Recruiting Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients
Condition: Malignant Female Reproductive System Neoplasm
Intervention: Drug: Enoxaparin, Heparin
33 Recruiting Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
Conditions: Venous Thromboembolic Disease;   Deep Vein Thrombosis;   Pulmonary Embolism
Interventions: Drug: 5000 Units unfractionated Heparin Q 8 hours;   Drug: 30mg enoxaparin Q12 hours
34 Recruiting Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children
Conditions: Infection of Intravenous Catheter;   Phlebitis;   Extravasation of Diagnostic and Therapeutic Materials
Interventions: Drug: 0,9% NaCl flush;   Drug: Heparin 50U/ml
35 Not yet recruiting Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery
Condition: Acquired Platelet Function Disorder
Intervention: Device: Balance surface, Carmeda heparin-coated surface
36 Recruiting Addition of Prednisolone and Heparin in Patients Undergoing Controlled Ovarian Hyperstimulation (COH) for In Vitro Fertilization (IVF) With Failed IVF Cycles
Condition: Infertility
Interventions: Drug: Prednisolone and Heparin during COH for IVF;   Drug: COH for IVF
37 Unknown  Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
Condition: Coronary Artery Disease
Interventions: Drug: Bivalirudin;   Drug: Heparin
38 Recruiting Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin
Condition: Thrombosis
Intervention: Drug: Heparin
39 Recruiting Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism
Condition: This Study Will Provide Data Comparing Safety of LMWH Versus UFH in the Treatment of Acute PE Cases Who Require Thrombolytic Treatment.
Intervention: Drug: enoxaparin ,alteplase, unfractionated heparin
40 Recruiting SuperB Trial: SUrgical Versus PERcutaneous Bypass
Condition: Cardiovascular Diseases
Intervention: Procedure: heparin-bonded ePTFE endoluminal fem-pop bypass

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years